Andrew Bolt

Andy Bolt is a principal in Deloitte’s Life Sciences Strategy practice and is the leader of the R&D Practice. He has more than 25 years of experience working in the life sciences industry, and his career spans from bench scientist to CEO. Bolt’s past client engagement experiences span the value chain from R&D to commercial, and his primary focus is on helping biopharma companies harness the power of data and AI to transform R&D. Bolt has an MBA from the Darden School of Business at UVA, in addition to an M.S. in Pharmaceutical Sciences and a B.S. in Molecular Biology, both from the University of Connecticut.